Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCD/IE in Ewing's Sarcoma
NCT00568464Phase 2Terminated
- Sponsor
- Fudan University
- Start
- Mar 2007
- Primary completion
- May 2009
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vincristine, cyclophosphamide, doxorubicin, ifosfamide, etoposide in Ewing sarcoma, sponsored by Fudan University. Started Mar 2007; status: terminated.
02
Drugs
vincristinecyclophosphamidedoxorubicinifosfamideetoposide
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT00568464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568464.